Franken IA, van der Baan FH, Vink GR, May AM, et al. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months. Eur J Cancer 2024;208:114207.
PMID: 39024724